Science Explorer Back to mapMap
Discussion
Topic · Dermatology

Skin Diseases and Diabetes

Skin Diseases and Diabetes is a research topic within Dermatology. Science Explorer counts 13k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the impact of obesity on skin physiology and the development of various skin disorders, including cutaneous manifestations, musculoskeletal disorders, diabetes mellitus-related skin issues, acanthosis nigricans, granuloma annulare, scleromyxedema, necrobiosis lipoidica, and the concept of the immunocompromised district. The papers cover a wide range of topics related to the dermatological complications and musculoskeletal manifestations associated with obesity and diabetes mellitus.

  • Obesity
  • Skin Physiology
  • Cutaneous Manifestations
  • Musculoskeletal Disorders
  • Diabetes Mellitus
  • Acanthosis Nigricans
  • Granuloma Annulare
  • Scleromyxedema
  • Necrobiosis Lipoidica
  • Immunocompromised District
Research works
13k
fractional, since 1950
In the world top 10%
1.3k
per year above
Top-10% rate
10.3%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+13%
the tick is no change
Largest producer
United States
28% of the 10 largest, 2022-now
Skin Diseases and Diabetes

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Skin Diseases and Diabetes research?

By volume, the United States and India publish the most (503 and 335 works in 2022-now).

By volume, 2022-now

  1. 1 United States 503 works
  2. 2 India 335 works
  3. 3 China 241 works
  4. 4 France 112 works
  5. 5 Japan 109 works
  6. 6 Spain 98 works
  7. 7 Italy 97 works
  8. 8 Brazil 96 works
  9. 9 United Kingdom 94 works
  10. 10 Germany 89 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.3%India: 18.9%China: 13.6%France: 6.3%6 others listed: 32.9%28%largest
United States503 · 28.3%India335 · 18.9%China241 · 13.6%France112 · 6.3%6 others listed585 · 32.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Skin Diseases and Diabetes research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Skin Diseases and Diabetes research, followed by Harvard University and Mayo Clinic.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 32 works
  2. 2 Harvard UniversityUnited States 16 works
  3. 3 Mayo ClinicUnited States 16 works
  4. 4 Université Paris CitéFrance 15 works
  5. 5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 13 works
  6. 6 Banaras Hindu UniversityIndia 13 works
  7. 7 Sichuan UniversityChina 11 works
  8. 8 Shanghai Jiao Tong UniversityChina 11 works
  9. 9 University of DelhiIndia 10 works
  10. 10 Yale UniversityUnited States 10 works

Who are the leading researchers in Skin Diseases and Diabetes?

The most-cited researchers publishing on Skin Diseases and Diabetes include Gregory Y.H. Lip, Yousef Saleh Khader and Richard Anthony Flavell.

  1. 1 Gregory Y.H. Lip United Kingdom 311k citations
  2. 2 Yousef Saleh Khader Jordan 274k citations
  3. 3 Richard Anthony Flavell United States 237k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Skin Diseases and Diabetes?

The most cited paper in Skin Diseases and Diabetes is "Preliminary criteria for the classification of systemic sclerosis (scleroderma)" (Alfonse T. Masi, 1980), with 4,957 citations. Next come "A RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSE" (3,476) and "Polymyositis and dermatomyositis" (1,421).

Most cited papers
#PaperReleasedCitations
1 Preliminary criteria for the classification of systemic sclerosis (scleroderma) Alfonse T. Masi · Arthritis & Rheumatism May 1980 4,957
2 A RELATION BETWEEN NON-ESTERIFIED FATTY ACIDS IN PLASMA AND THE METABOLISM OF GLUCOSE Vincent P. Dole · Journal of Clinical Investigation Open access Feb 1956 3,476
3 Polymyositis and dermatomyositis Marinos C. Dalakas, Reinhard Hohlfeld · The Lancet Sep 2003 1,421
4 Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases Cristina Galván‐Casas et al. · British Journal of Dermatology Open access 29 Apr 2020 1,242
5 The Syndromes of Insulin Resistance and Acanthosis Nigricans C. Ronald Kahn, Jeffrey S. Flier, Robert S. Bar et al. · New England Journal of Medicine Apr 1976 1,110
All 100 most cited papers, with filters and sorting

Where is Skin Diseases and Diabetes research done?

The largest centres of Skin Diseases and Diabetes research in 2022-now are Beijing (China), Paris (France), New Delhi (India) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Tunis.

Largest cities, 2022-now

  1. 1 BeijingChina 48 works
  2. 2 ParisFrance 37 works
  3. 3 New DelhiIndia 32 works
  4. 4 ShanghaiChina 30 works
  5. 5 LondonUnited Kingdom 27 works
  6. 6 MadridSpain 24 works
  7. 7 São PauloBrazil 24 works
  8. 8 TokyoJapan 21 works
  9. 9 TunisTunisia 21 works
  10. 10 New YorkUnited States 21 works

Where it is the local speciality

  1. TunisTN · 21.3 works12×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Skin Diseases and Diabetes than the world average.

See Skin Diseases and Diabetes on the map

Where is the best place to study Skin Diseases and Diabetes?

Among universities, judged by research, Harvard University, Johns Hopkins University and Sichuan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 14.68%fractional works in this field (log) →share of work in the world top 10% →Sichuan UniversityJohns Hopkins Univer…Harvard UniversityAll India Institute …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 58.911.9%2.0×16 +50.9%
2Johns Hopkins UniversityUnited States 54.224.6%2.4×9 +1.0%
3Sichuan UniversityChina 53.227.8%2.0×11 +470.8%
4All India Institute of Medical SciencesIndia 52.82.8%11.7×32 +91.5%
5Yale UniversityUnited States 50.317.4%3.6×10 +43.1%
6Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 48.315.8%5.1×13 +79.2%
7Peking UniversityChina 42.821.0%1.8×9 +85.8%
8Université Paris CitéFrance 41.94.6%8.1×15 -5.8%
9Shanghai Jiao Tong UniversityChina 40.416.4%1.5×11 +59.6%
10University of DelhiIndia 33.04.5%6.2×10 +95.0%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Skin Diseases and Diabetes, country by country

Is Skin Diseases and Diabetes research growing?

Output in 2022-2025 was 13% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Skin Diseases and Diabetes.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Skin Diseases and Diabetes as a percentage of every work published that year, 0.0099% in 2024.

still counting0.010%0.020%Skin Diseases and Diabetes0.012% in 202519801990200020102020

Fractional works of Skin Diseases and Diabetes over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Skin Diseases and Diabetes10.6% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Skin Diseases and Diabetes. Posts are plain text and can be reported.